Aeterna Zentaris (AEZS) Misses Q2 EPS by 6c

Aeterna Zentaris (NASDAQ: AEZS) reported Q2 EPS of ($0.14), $0.06 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $197 thousand versus the consensus estimate of $550 thousand.

For earnings history and earnings-related data on Aeterna Zentaris (AEZS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c